AbbVie
ABBV
ABBV
1,724 hedge funds and large institutions have $71.2B invested in AbbVie in 2017 Q1 according to their latest regulatory filings, with 123 funds opening new positions, 650 increasing their positions, 741 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,724
Holders Change
+36
Holders Change %
+2.13%
% of All Funds
42.98%
Holding in Top 10
83
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-2.35%
% of All Funds
2.07%
New
123
Increased
650
Reduced
741
Closed
70
Calls
$1.25B
Puts
$1.07B
Net Calls
+$188M
Net Calls Change
+$176M
Top Buyers
| 1 |
BlackRock
New York
|
$6.01B |
| 2 |
Morgan Stanley
New York
|
$1.12B |
| 3 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
$610M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$7.31B |
| 5 |
D.E. Shaw & Co
New York
|
$222M |
